×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DTIL – precision biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DTIL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
07:23 am
dtil
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B [Yahoo! Finance]
High
Report
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B [Yahoo! Finance]
4/15
07:01 am
dtil
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
High
Report
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B
4/8
09:10 am
dtil
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer [Yahoo! Finance]
Low
Report
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer [Yahoo! Finance]
4/1
07:01 am
dtil
Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/28
08:20 am
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Neutral
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
3/26
07:14 am
dtil
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/26
07:01 am
dtil
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update
High
Report
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update
3/25
11:28 am
dtil
Prendio-BioProcure Launches New Generative AI, Analytics, and Workflow Automation Capabilities Enhancing its Market Leading Life Sciences P2P Technology Solution [Yahoo! Finance]
Medium
Report
Prendio-BioProcure Launches New Generative AI, Analytics, and Workflow Automation Capabilities Enhancing its Market Leading Life Sciences P2P Technology Solution [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/26/2025
07:01 am
DTIL
precision biosciences, inc.
MISS
Report
-15.5%
precision biosciences, inc.
11/4/2024
07:01 am
DTIL
precision biosciences, inc.
MISS
Report
-8.1%
precision biosciences, inc.
8/1/2024
07:15 am
DTIL
precision biosciences, inc.
BEAT
Report
0.6%
precision biosciences, inc.
5/13/2024
07:00 am
DTIL
precision biosciences, inc.
BEAT
Report
3.5%
precision biosciences, inc.
Date
Time
Symbol
Headline
Impact
4/15
08:11 am
dtil
Form ARS PRECISION BIOSCIENCES For: Dec 31
High
Report
Form ARS PRECISION BIOSCIENCES For: Dec 31
4/15
08:10 am
dtil
Form DEFA14A PRECISION BIOSCIENCES
High
Report
Form DEFA14A PRECISION BIOSCIENCES
4/15
08:09 am
dtil
Form DEF 14A PRECISION BIOSCIENCES For: May 28
High
Report
Form DEF 14A PRECISION BIOSCIENCES For: May 28
4/4
07:38 am
dtil
Form PRE 14A PRECISION BIOSCIENCES For: May 28
Low
Report
Form PRE 14A PRECISION BIOSCIENCES For: May 28
3/28
07:02 am
dtil
Form 4 PRECISION BIOSCIENCES For: Mar 26 Filed by: Buehler Kevin
Medium
Report
Form 4 PRECISION BIOSCIENCES For: Mar 26 Filed by: Buehler Kevin
3/28
07:00 am
dtil
Form 4 PRECISION BIOSCIENCES For: Mar 26 Filed by: Brown Melinda
Medium
Report
Form 4 PRECISION BIOSCIENCES For: Mar 26 Filed by: Brown Melinda
3/27
07:00 am
dtil
Form 4 PRECISION BIOSCIENCES For: Mar 25 Filed by: Germano Geno J
Medium
Report
Form 4 PRECISION BIOSCIENCES For: Mar 25 Filed by: Germano Geno J
3/26
06:10 pm
dtil
Form SCHEDULE 13G PRECISION BIOSCIENCES Filed by: Readout Capital, LP
Low
Report
Form SCHEDULE 13G PRECISION BIOSCIENCES Filed by: Readout Capital, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/13
Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
24.6%
4/6 Form 8-K PRECISION BIOSCIENCES For: Apr 06 21.4%
11/6 Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting 18.6%
1/8 Form 4 PRECISION BIOSCIENCES For: Jan 06 Filed by: ANSARI ABID 17.3%
3/12 Form 3 PRECISION BIOSCIENCES For: Mar 10 Filed by: Germano Geno J 13.8%
4/28 Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting 6.8%
4/8 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock. 6.4%
11/12 Form 10-Q PRECISION BIOSCIENCES For: Sep 30 5.7%
2/24 Precision BioSciences: Consider Taking Up A Small Position [Seeking Alpha] 5.4%
11/13 Form 3 PRECISION BIOSCIENCES For: Nov 08 Filed by: Buehler Kevin 5.3%
4/6 Form 8-K PRECISION BIOSCIENCES For: Apr 06 21.4%
11/6 Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting 18.6%
1/8 Form 4 PRECISION BIOSCIENCES For: Jan 06 Filed by: ANSARI ABID 17.3%
3/12 Form 3 PRECISION BIOSCIENCES For: Mar 10 Filed by: Germano Geno J 13.8%
4/28 Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting 6.8%
4/8 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock. 6.4%
11/12 Form 10-Q PRECISION BIOSCIENCES For: Sep 30 5.7%
2/24 Precision BioSciences: Consider Taking Up A Small Position [Seeking Alpha] 5.4%
11/13 Form 3 PRECISION BIOSCIENCES For: Nov 08 Filed by: Buehler Kevin 5.3%
TOP News Decliners
12/9
Precision BioSciences stock rises on early-stage CAR-T trial data [MarketWatch]
-54.5%
3/12 Form 8-K PRECISION BIOSCIENCES For: Mar 12 -16.5%
4/15 Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources -16.4%
8/9 Precision BioSciences Inc (NASDAQ: DTIL) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock. -16.3%
4/2 Precision BioSciences Inc (NASDAQ: DTIL) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating. -15.9%
3/11 Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano -14.6%
1/15 Form 8-K/A PRECISION BIOSCIENCES For: Jan 15 -12.4%
1/13 Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma -8.0%
9/25 Form 4 PRECISION BIOSCIENCES For: Sep 23 Filed by: KANE MATTHEW R. -7.7%
2/7 Form SC 13G PRECISION BIOSCIENCES Filed by: BlackRock Inc. -7.1%
3/12 Form 8-K PRECISION BIOSCIENCES For: Mar 12 -16.5%
4/15 Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources -16.4%
8/9 Precision BioSciences Inc (NASDAQ: DTIL) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock. -16.3%
4/2 Precision BioSciences Inc (NASDAQ: DTIL) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating. -15.9%
3/11 Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano -14.6%
1/15 Form 8-K/A PRECISION BIOSCIENCES For: Jan 15 -12.4%
1/13 Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma -8.0%
9/25 Form 4 PRECISION BIOSCIENCES For: Sep 23 Filed by: KANE MATTHEW R. -7.7%
2/7 Form SC 13G PRECISION BIOSCIENCES Filed by: BlackRock Inc. -7.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: